ISTH/LinkedIn
May 19, 2026, 15:57
Explore the Emerging Science Behind Factor XI/XIa Inhibition on the ISTH Academy – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“What if stroke prevention didn’t have to come with the same level of bleeding risk?
Explore the emerging science behind factor XI/XIa inhibition in this new learning resource on the ISTH Academy.
Review the role of FXI in thrombosis and hemostasis, examine key clinical trial data and discover how these therapies may reshape secondary stroke prevention.
- Includes real-world clinical scenarios
- CME credit available upon completion
Start learning today with the ISTH Academy.”

Other posts featuring International Society on Thrombosis and Haemostasis on Hemostasis Today.
-
Nov 20, 2026, 00:27Vera Stroikova: Key Takeaways on Electrophysiology and Stroke Prevention From the New Horizons 2026
-
Nov 20, 2026, 00:20Devi G. Nair Enrolls First US Patient in Smartphone Camera Atrial Fibrillation Detection Study
-
Nov 20, 2026, 00:14Saskia de Pee: Fortified Rice Cuts Anemia Risk by 57%
-
Nov 20, 2026, 00:02Andres Zuleta: Evaluating the RISE UP Trial Results on Mitapivat for Sickle Cell Disease
-
Nov 19, 2026, 23:57Greta Hametner: Preventing Maternal Cardiac Complications Through Preconception Iron and Thyroid Screening
-
Nov 19, 2026, 23:49Cyrus Shariat: Why Waiting for Lab Results Can Be Fatal in HIT
-
Nov 19, 2026, 22:24Erik Nelson: Low Iron Can Raise A1c without Changing Blood Sugar
-
Nov 19, 2026, 22:23Erwin Loh: Daily Iron Supplementation Reduces Iron-Deficiency Anaemia in Children and Adolescents
-
Nov 19, 2026, 22:22Afifah Sardar: Why Can a Simple Painkiller like Aspirin Make You Bleed More?